论文部分内容阅读
目的:胆汁淤积性病毒性肝炎对患者影响较大,采用腺苷蛋氨酸治疗进行治疗,对其临床效果进行观察。方法:将92例胆汁淤积性病毒性肝炎患者根据所接受治疗方法的不同分为两组(n=46),分别采用腺苷蛋氨酸治疗(实验组)和门冬氨酸钾镁治疗,对两组治疗后的临床效果和生化指标的变化进行比较。结果:治疗有效率93.48%(实验组)明显较有效率76.09%(对照组)高,组间数据相比存在较为明显的差异P<0.05,实验组的生化观察指标与对照组相比较低,组间数据相比具有统计学意义P<0.05。结论:胆汁淤积性病毒性肝炎对患者的身体健康存在较大的威胁,而使用腺苷蛋氨酸治疗能够提高其临床治疗效果,并有效改善了患者的生化指标,效果较好,值得临床推广。
Objective: Cholestatic viral hepatitis has a great impact on patients with adenosine methionine therapy, and its clinical effect was observed. Methods: A total of 92 patients with cholestatic viral hepatitis were divided into two groups (n = 46) according to the method of treatment. Adenosine methionine (experimental group) and potassium and magnesium aspartate Group after treatment, the clinical effect and biochemical changes were compared. Results: The effective rate of treatment was 93.48% (experimental group), the effective rate was 76.09% (control group), the difference between the two groups was significant (P <0.05). The biochemical indexes in the experimental group were lower than those in the control group The data between groups were statistically significant P <0.05. Conclusion: Cholestatic viral hepatitis poses a great threat to the health of patients. However, the use of adenosylmethionine can improve the clinical effect and improve the biochemical indexes of patients. The results are worthy of clinical promotion.